Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results

EXAGEN INC. (XGN) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/07/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/07/2023 8-K Results of Operations and Financial Condition, Financial Statements and Exhibits  Interactive Data
Docs: "Exagen Inc. Reports Strong Second Quarter 2023 Results"
07/24/2023 8-K Quarterly results
05/24/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/18/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/04/2023 8-K Quarterly results
03/23/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/20/2023 10-K Annual Report for the period ended December 31, 2022
03/20/2023 8-K Quarterly results
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/09/2023 SC 13G/A WASATCH ADVISORS INC reports a 6.1% stake in Exagen Inc.
02/07/2023 SC 13G/A TULLIS DICKERSON CAPITAL FOCUS III, L.P. reports a 11.4% stake in Exagen, Inc.
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/02/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/23/2023 SC 13G/A Cowen Financial Products LLC reports a 5.9% stake in Exagen Inc.
01/23/2023 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and ...
Docs: "AMENDMENT TO THE AMENDED AND RESTATED BYLAWS OF",
"Exagen Inc. Elects Tina S. Nova, Ph.D."
01/09/2023 8-K Quarterly results
12/05/2022 8-K Quarterly results
11/23/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
11/21/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/21/2022 10-Q/A Quarterly Report for the period ended June 30, 2022 [amend]
11/14/2022 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
11/14/2022 8-K Quarterly results
Docs: "Exagen Inc. Reports Third Quarter 2022 Results"
10/20/2022 8-K Quarterly results
09/15/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
09/15/2022 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "EXAGEN INC. $50,000,000",
"BOSTON LONDON LOS ANGELES NEW YORK SAN DIEGO SAN FRANCISCO WASHINGTON"
08/04/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/04/2022 8-K Quarterly results
Docs: "Exagen Inc. Reports Second Quarter 2022 Results"
06/21/2022 8-K Quarterly results
05/11/2022 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
05/11/2022 10-Q Quarterly Report for the period ended March 31, 2022
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy